Colgate-Palmolive (NYSE:CL) SVP John J. Huston sold 10,170 shares of the company’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $71.05, for a total value of $722,578.50. Following the sale, the senior vice president now owns 48,965 shares of the company’s stock, valued at $3,478,963.25. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Colgate-Palmolive stock opened at $71.37 on Friday. The company has a current ratio of 1.13, a quick ratio of 0.78 and a debt-to-equity ratio of 32.25. The company has a market capitalization of $61.51 billion, a PE ratio of 25.15, a P/E/G ratio of 4.61 and a beta of 0.76. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $76.41. The stock has a 50-day moving average price of $72.54 and a two-hundred day moving average price of $69.90.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.
Several analysts recently weighed in on CL shares. Argus upped their price objective on Colgate-Palmolive from $72.00 to $82.00 and gave the stock a “buy” rating in a research report on Tuesday, June 11th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price objective for the company. in a research report on Friday, June 7th. UBS Group upped their price objective on Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Bank of America set a $80.00 price objective on Colgate-Palmolive and gave the stock a “buy” rating in a research report on Friday, July 12th. Finally, Piper Jaffray Companies started coverage on Colgate-Palmolive in a research report on Tuesday. They set an “overweight” rating for the company. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $73.13.
A number of institutional investors have recently bought and sold shares of the business. Krane Funds Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $25,000. Meridian Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $29,000. Lipe & Dalton acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $29,000. WP Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $34,000. Finally, Enterprise Trust & Investment Co acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $36,000. Hedge funds and other institutional investors own 75.64% of the company’s stock.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Story: What is Cost of Goods Sold (COGS)?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.